FDA to Review Perrigo’s Birth Control Pill for Over-the-Counter Use

The corporate logo of the Food and Drug Administration (FDA) in Silver Spring, Md., on Nov. 4, 2009. Jason Reed/Reuters

Perrigo Co. Plc. said on Monday that the U.S. Food and Drug Administration (FDA) has scheduled a meeting of external experts on Nov. 18 to review the application of its daily birth control pill for over-the-counter (OTC) use.

Contraception access has taken the spotlight since the U.S. Supreme Court’s decision in June to overturn the 1973 Roe v. Wade case that legalized abortion nationwide.